Clinical management of infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: A nationwide survey of tertiary hospitals in mainland China

•The present study included data from 212 tertiary hospitals in mainland China;. •Only 16% of the participating hospitals routinely offered ceftazidime-avibactam for treating carbapenem-resistant klebsiella pneumoniae infections;. •Tigecycline plus a carbapenem was the preferred combination for carbapenem-resistant klebsiella pneumoniae infections;.